Table B.1.
Occurrence of resistance to third‐generation cephalosporins and fluoroquinolones in non‐typhoidal Salmonella spp. from food‐producing animals, animal carcases and humans, reported by MSs in 2019–2020
| Human/animal category | No. of MSs | N | Cefotaxime | Ceftazidime | Ciprofloxacin/Pefloxacin | |||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||
| Humans – 2020* | See footnote below | – | 0.8( a ) | – | 0.8%( b ) | – | 14.1%( c ) | |
| Humans – 2019* | – | 1.8%( d ) | – | 1.2%( e ) | – | 13.5%( f ) | ||
| Broiler carcases – 2020 | 18 MSs | 905 | 3 | 0.1% | 1 | 0.1% | 627 | 69.3% |
| Turkey carcases – 2020 | 8 MSs | 320 | 0 | 0% | 0 | 0% | 150 | 46.9% |
| Pig carcases – 2019 | 26 MSs | 1,088 | 5 | 0.5% | 5 | 0.5% | 88 | 8.1% |
| Calf carcases (< 1 year) – 2019 | 7 MSs | 91 | 0 | 0 | 0 | 0 | 2 | 2.2% |
| Broilers – 2020 | 22 MSs | 1,955 | 41 | 2.1% | 42 | 2.2% | 1,125 | 57.5% |
| Laying hens – 2020 | 24 MSs | 1,030 | 4 | 0.4% | 4 | 0.4% | 196 | 19.1% |
| Fattening turkeys – 2020 | 16 MSs | 674 | 3 | 0.5% | 3 | 0.5% | 438 | 64.9% |
| Fattening pigs – 2019 | 8 MSs | 359 | 4 | 1.1% | 4 | 1.1% | 21 | 5.8% |
| Calves (< 1 year) – 2019 | 3 MSs | 64 | 0 | 0 | 0 | 0 | 8 | 12.5% |
N: Total number of isolates tested/reported by MSs; n: Total number of isolates resistant; MSs: Member states.
*: In several countries, ciprofloxacin has been replaced by pefloxacin for screening for fluoroquinolone resistance with disk diffusion, as recommended by EUCAST.
(a)
N = 7,101, 190 MSs.
(b)
N = 6,000, 16 MSs.
(c)
N = 6,906, 20 MSs.
(d)
N = 16,414, 24 MSs.
(e)
N = 14,356, 20 MSs.
(f)
N = 18,397, 24 MSs.